Centre for Addiction and Mental Health, University of Toronto, Toronto, ON ONM5T 1R8, Canada.
Biol Psychiatry. 2010 Mar 1;67(5):458-64. doi: 10.1016/j.biopsych.2009.09.025. Epub 2009 Nov 17.
Several lines of evidence suggest that major depressive disorder is associated with deficits in gamma-aminobutyric acid (GABA) inhibitory neurotransmission. Transcranial magnetic stimulation represents a noninvasive technique to measure cortical inhibition. In this study, we endeavored to measure cortical inhibition in medicated patients with treatment resistant major depressive disorder (TRD), unmedicated patients with major depressive disorder, and medicated euthymic patients with a history of major depressive disorder and compare them with healthy subjects.
Twenty-five patients with TRD, 16 unmedicated patients with major depressive disorder, 19 medicated euthymic patients with previous major depressive disorder (i.e., 17-item Hamilton Rating Scale for Depression < 8), and 25 healthy subjects were enrolled. Cortical inhibition was measured with transcranial magnetic stimulation paradigms known as short-interval cortical inhibition and the cortical silent period, which index GABA(A) and GABA(B) receptor-mediated inhibitory neurotransmission, respectively.
All major depressive disorder patient groups demonstrated significant cortical silent period deficits compared with healthy subjects. By contrast, only TRD patients demonstrated significant deficits in short-interval cortical inhibition compared with healthy subjects, medicated euthymic major depressive disorder patients, and unmedicated major depressive disorder patients. The TRD patients also demonstrated a significantly greater resting motor threshold compared with all other clinical subgroups and healthy subjects, suggesting that TRD was also associated with hypoexcitability of the frontal cortex.
Our findings suggest that GABA(B) neurophysiological deficits are closely related to pathophysiology of major depressive disorder. Our findings also suggest that more severe illness is selectively associated with GABA(A) receptor-mediated inhibitory deficits.
有几条证据表明,重度抑郁症与γ-氨基丁酸(GABA)抑制性神经传递的缺陷有关。经颅磁刺激代表了一种测量皮质抑制的非侵入性技术。在这项研究中,我们试图测量有治疗抵抗的重度抑郁症(TRD)的药物治疗患者、无药物治疗的重度抑郁症患者以及有重度抑郁症病史且处于情绪稳定状态的药物治疗患者的皮质抑制,并将其与健康受试者进行比较。
共纳入 25 名 TRD 患者、16 名无药物治疗的重度抑郁症患者、19 名有重度抑郁症病史且处于情绪稳定状态的药物治疗患者(即 17 项汉密尔顿抑郁量表评分<8)和 25 名健康受试者。皮质抑制采用经颅磁刺激范式进行测量,这些范式包括短程皮质抑制和皮质静息期,分别反映 GABA(A)和 GABA(B)受体介导的抑制性神经传递。
所有重度抑郁症患者组与健康受试者相比,皮质静息期均存在显著缺陷。相比之下,只有 TRD 患者与健康受试者、有药物治疗的情绪稳定的重度抑郁症患者和无药物治疗的重度抑郁症患者相比,短程皮质抑制存在显著缺陷。TRD 患者的静息运动阈值也明显高于所有其他临床亚组和健康受试者,这表明 TRD 还与前额皮质的兴奋性降低有关。
我们的研究结果表明,GABA(B)神经生理缺陷与重度抑郁症的病理生理学密切相关。我们的研究结果还表明,更严重的疾病与 GABA(A)受体介导的抑制缺陷选择性相关。